CEROGENIX
CEROGENIX
Industry:
Health Care Health Diagnostics Pharmaceutical
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
Total Funding:
370 K GBP
Similar Organizations
Boehringer Mannheim
Boehringer Mannheim is a Germany-based maker of drugs and diagnostic products.
Detectan
Detectan is a medical innovation company for diagnostics.
GryNumber Health
GryNumber Health is a commercial-stage pharma and diagnostics company.
Transition Bio
Transition Bio provides condensate technology for drug discovery and diagnostics.
Investors List
IP Group
IP Group investment in Seed Round - Cerogenix
More informations about "Cerogenix"
Ceragenix Pharmaceuticals - Wikipedia
Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Denver, Colorado that develops prescription therapies based on a platform of proprietary surface active technologiesโskin Barrier Repair Technology (BRT) and Cerageninis, a new class of broad spectrum anti-infectives. The company discovers, develops and commercializes anti-infective drugs based on its proprietary class of compounds, Ceragenins. Active against a range of gram positiveSee details»
Cerogenix - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 14, 2005: Seed Round - โฆSee details»
Cerogenix - Crunchbase
Cerogenix is a drug discovery and diagnostics. Start Free Trial . Chrome ExtensionSee details»
Cerogenix Ltd. - life-sciences-europe.com
Life Sciences Business Intelligence Web Portal for European countriesSee details»
Ceragenix Pharmaceuticals Inc - Company Profile and News
Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company. The Company offers development and commercialization of innovative products in dermatology and infectious disease. ...See details»
Ceragenix Pharmaceuticals - Overview, News & Similar companies ...
Who is Ceragenix Pharmaceuticals. Ceragenix Pharmaceuticals, Inc. is a medical device company focused on infectious disease and dermatology. The Company has two base โฆSee details»
Cerogenix - Products, Competitors, Financials, Employees, โฆ
Use the CB Insights Platform to explore Cerogenix's full profile. Cerogenix - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»
Organization | Ceragenix Pharmaceuticals
Ceragenix Pharmaceuticals Report issue. For profit Phase 4. Founded: Denver CO United States ... Organization Overview. First Clinical Trial. 2006 NCT00616538. First Marketed Drug. None โฆSee details»
Cerogenix - Products, Competitors, Financials, Employees, โฆ
Cerogenix develops novel therapeutics for neurological diseases such as Alzheimer's and Parkinson's disease. Use the CB Insights Platform to explore Cerogenix's full profile.See details»
Cerogenix - VentureRadar
Similar Companies: neuroClues Unknown n/a neuroClues specializes in developing an eye-tracking technology designed to identify and monitor neurological diseases before symptoms โฆSee details»
Ceragenix Pharmaceuticals - Wikiwand
Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Denver, Colorado that develops prescription therapies based on a platform of proprietary surface active technologiesโskin Barrier Repair Technology (BRT) and Cerageninis, a new class of broad spectrum anti-infectives. [1] The company discovers, develops and commercializes anti โฆSee details»
Cerogenix Management Team - CB Insights
Explore {Cerogenix's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Cerogenix CEO, Founder, Key Executive Team, Board of Directors & EmployeesSee details»
Cerogenix Stock Price, Funding, Valuation, Revenue ... - CB Insights
See Cerogenix funding rounds, investors, investments, exits and more. Evaluate their financials based on Cerogenix's post-money valuation and revenue. Cerogenix Stock Price, Funding, โฆSee details»
OnSource Corporation Changes Name to Ceragenix Pharmaceuticals
Jul 7, 2005 OnSource Corporation has changed its name to Ceragenix Pharmaceuticals, Inc. The change in name follows the merger of OnSource with Osmotics Pharma, Inc. on May 11, โฆSee details»
Ivan Griffin: Positions, Relations and Network - MarketScreener
May 28, 2019 Cerogenix Ltd. provides pharmaceutical research and development services. The company focuses on developing therapeutics for the treatment of neurological diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. Cerogenix was founded in September, 2005 by Adrian Pini and is located in London, UK ...See details»
Ceragenin - Drug Targets, Indications, Patents - Synapse
Ceragenin, Initially developed by Ceragenix Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Infectious Diseases. Biomedical products. Data. โฆSee details»
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpaceSee details»
Ceragenix Enters into Agreement to License CSA-54 and other โฆ
Mar 25, 2008 Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical and medical device company focused on infectious disease and dermatology. The Company has two base โฆSee details»
Cerogenix Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Cerogenix Ltd including stock price, company news, executives, board members, and contact informationSee details»